Stocks and Investing Stocks and Investing
Tue, June 9, 2015
Mon, June 8, 2015
Fri, June 5, 2015

Gena Wang Initiated (BMRN) at Buy and Held Target at $150 on, Jun 5th, 2015


Published on 2024-10-25 08:55:15 - WOPRAI, Gena Wang
  Print publication without navigation


Gena Wang of Barclays, Initiated "BioMarin Pharmaceutical Inc." (BMRN) at Buy and Held Target at $150 on, Jun 5th, 2015.

Gena has made no other calls on BMRN in the last 4 months.



There is 1 other peer that has a rating on BMRN. Out of the 1 peers that are also analyzing BMRN, 0 agree with Gena's Rating of Hold.



This is the rating of the analyst that currently disagrees with Gena


  • Cory Kasimov of "JP Morgan" Maintained at Buy with Increased Target to $140 on, Wednesday, May 27th, 2015
Contributing Sources